DE LUCA, MARIA ANTONIETTA
 Distribuzione geografica
Continente #
EU - Europa 174.929
NA - Nord America 8.084
AS - Asia 4.068
SA - Sud America 686
AF - Africa 118
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 187.905
Nazione #
IT - Italia 172.478
US - Stati Uniti d'America 7.941
SG - Singapore 1.596
CN - Cina 1.327
BR - Brasile 543
UA - Ucraina 470
SE - Svezia 460
VN - Vietnam 393
DE - Germania 362
FI - Finlandia 249
NL - Olanda 231
GB - Regno Unito 198
FR - Francia 191
HK - Hong Kong 155
IN - India 114
BD - Bangladesh 89
KR - Corea 79
CA - Canada 73
AR - Argentina 49
JP - Giappone 46
PL - Polonia 40
RU - Federazione Russa 39
MX - Messico 36
IQ - Iraq 34
ES - Italia 33
MA - Marocco 31
ZA - Sudafrica 30
TR - Turchia 27
CH - Svizzera 25
PK - Pakistan 25
AT - Austria 23
BE - Belgio 23
ID - Indonesia 23
CO - Colombia 21
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
EC - Ecuador 17
UZ - Uzbekistan 16
VE - Venezuela 16
IE - Irlanda 15
KE - Kenya 14
CL - Cile 13
AU - Australia 12
PH - Filippine 12
TW - Taiwan 12
IL - Israele 11
DZ - Algeria 10
EG - Egitto 10
JM - Giamaica 10
MY - Malesia 10
IR - Iran 9
PY - Paraguay 9
RO - Romania 9
JO - Giordania 8
LT - Lituania 8
PT - Portogallo 8
TN - Tunisia 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
EU - Europa 7
KZ - Kazakistan 7
PE - Perù 7
RS - Serbia 7
UY - Uruguay 7
GR - Grecia 6
HU - Ungheria 6
LV - Lettonia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
CY - Cipro 5
KG - Kirghizistan 5
LB - Libano 5
PA - Panama 5
AM - Armenia 4
EE - Estonia 4
NP - Nepal 4
PS - Palestinian Territory 4
SN - Senegal 4
BY - Bielorussia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
OM - Oman 3
SY - Repubblica araba siriana 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
ET - Etiopia 2
GT - Guatemala 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
NO - Norvegia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 187.888
Città #
Cagliari 167.227
Uta 3.503
Singapore 811
Ashburn 797
Fairfield 710
San Jose 508
Woodbridge 503
Chandler 424
Dallas 396
Houston 344
Boardman 329
Nyköping 288
Beijing 284
Wilmington 268
Ann Arbor 267
Jacksonville 256
Dearborn 249
Cambridge 225
Seattle 224
Helsinki 162
Milan 157
Los Angeles 142
Santa Clara 140
Hong Kong 138
The Dalles 134
Council Bluffs 130
Ho Chi Minh City 128
New York 107
Nanjing 101
Shanghai 100
Lauterbourg 94
Hefei 91
Boston 89
Rome 89
Hanoi 77
Seoul 70
Munich 66
Buffalo 63
Orem 53
Frankfurt am Main 51
São Paulo 48
Dong Ket 44
Guangzhou 42
Tokyo 32
Toronto 32
Chennai 31
Nanchang 31
Florence 30
San Diego 30
Atlanta 27
London 27
Chicago 26
Changsha 25
Shenyang 25
Hebei 24
Jiaxing 23
Phoenix 23
Redwood City 23
Brooklyn 22
Casablanca 22
Tianjin 22
Montreal 21
Norwalk 21
Nuremberg 21
Verona 20
Amsterdam 19
Bologna 19
Reggio Emilia 19
Redondo Beach 18
San Francisco 18
Warsaw 18
Washington 18
Mountain View 16
Orange 16
Sassari 16
Stockholm 16
Villafranca di Verona 16
Wuhan 16
Belo Horizonte 15
Da Nang 15
Jinan 15
Mexico City 15
Paris 15
Johannesburg 14
Kunming 14
San Mateo 14
Vienna 14
Zhengzhou 14
Brasília 13
Brno 13
Brussels 13
Dublin 13
Düsseldorf 13
Manchester 13
Naples 13
Tashkent 13
Turin 13
Hangzhou 12
Lappeenranta 12
New Delhi 12
Totale 181.010
Nome #
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.378
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 4.163
Caffeine and the brain: an overview 3.737
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.504
Dopamine restores limbic memory loss, dendritic spine structure, and NMDAR-dependent LTD in the nucleus accumbens of alcohol-withdrawn rats 3.358
Endocannabinoid 2-arachidonoylglycerol self-administration by Sprague-Dawley rats and stimulation of in vivo dopamine transmission in the nucleus accumbens shell 3.273
Metronidazole prodrugs: Synthesis, physicochemical properties, stability, and ex vivo release studies 3.267
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.173
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 3.021
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics 2.941
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.784
LC-MS-MS determination of rotenone, deguelin, and rotenolone in human serum 2.725
Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement. 2.723
Role of dopamine D(1) receptors in caffeine-mediated ERK phosphorylation in the rat brain 2.707
Serotonergic signaling controls input-specific synaptic plasticity at striatal circuits 2.703
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: jwh-018 2.650
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.632
Loren Parsons' contribution to addiction neurobiology 2.564
Cannabis; epidemiological, neurobiological and psychopathological issues: an update 2.510
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.463
DOPAMINE MICRODIALYSIS IN THEACCUMBENS SHELL/COREAND PREFRONTAL COTEX AFTER ACUTE ANTIPSYCHOTICS 2.417
OX26 MAB IMMUNOLIPOSOMES FOR THE DELIVERY OF SENKTIDE TO THE BRAIN 2.391
Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli 2.338
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 2.331
Cannabinoidi sintetici 2.0: ecco cosa si cela all’interno delle spice drugs 2.328
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia 2.320
5HT/DA system interactions in the reinforcing properties of psychostimulants: role of 5-HT6 receptors 2.293
Sales and advertising channels of new psychoactive substances (NPS): Internet, social networks, and smartphone apps 2.290
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.260
Cannabinoids and drug addiction 2.247
Neuropharmacology of New psychoactive substances (NPS): Focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants 2.197
null 2.160
Influence of morphine sensitization on the responsiveness of mesolimbic and mesocortical dopamine transmission to appetitive and aversive gustatory stimuli 2.100
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 2.057
Is there a teratogenicity risk associated with cannabis and synthetic cannabimimetics' ('Spice') intake? 2.044
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses 2.024
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 2.016
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.003
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 1.982
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe 1.934
Erratum to: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (Nature Communications, (2018), 9, 1, (2265), 10.1038/s41467-018-04711-w) 1.872
4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study 1.854
Responsiveness of nucleus accumbens and prefrontal cortex dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.836
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.827
Studio degli effetti acuti e cronici e delle proprietà d'abuso del cannabinoide sintetico JWH-018: Un approccio multidisciplinare 1.799
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.772
Brain-wide mapping of endogenous serotonergic transmission via chemogenetic fMRI 1.761
Effect of mPFC 6-OHDA lesions in the NAc Shell DA response to appetitive stimuli 1.754
Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice 1.740
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48: Behavioral, neurochemical, and dopamine transporter scan imaging studies in mice 1.724
Behavioural and neurochemical rewarding properties of the endocannabinoid 2-arachidonylglycerol 1.715
Effect of medial prefrontal cortex 6-hydroxy-dopamine on the nucleus accumbens dopamine responsiveness to appetitive stimuli 1.715
Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences 1.714
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 1.699
Habituation of the responsiveness of mesolimbic and mesocortical dopamine transmission to taste stimuli 1.617
Cannabis come sostanza d'abuso 1.608
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.597
Interaction between 5-HT and DA in relation to the treatment of psychostimulant dependence 1.585
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.573
Possible role of 5-HT6 receptors in addictions - Possibile ruolo dei recettori 5-HT6 nelle dipendenze 1.571
Therapeutic Use of Synthetic Cannabinoids: Still an Open Issue? 1.534
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 1.523
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses 1.429
JWH-018: a cannabinoid compound of Spice drugs stimulates dopamine transmission in the nucleus accumbens shell 1.402
Pharmacological and behavioral effects of the synthetic cannabinoid akb48 in rats 1.379
Taste novelty and dopamine in Food Neophobia Behavioral and Biological Influences 1.368
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment 1.347
Strategies of intervention to limit the novel synthetic opioids (NSO) escalation in Europe 1.318
Typical and atypical antipsychotics: effects on motor behavior and differential responsiveness of shell/core/prefrontal cortex dopamine transmission 1.313
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.269
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.249
Caffeine and accumbens shell dopamine 1.242
Editorial: Deconstructing the influence of genetic and age vulnerability to psychiatric disorders 1.239
Activation of PPAR gamma by the anti-diabetic agent pioglitazone reduces opioid reinforcement and opioid- induced activation of the mesolimbic dopamine system 1.221
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.201
null 1.194
Caffeine and Accumbens shell dopamine 1.192
Responsiveness of n. accumbens dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.130
Responsiveness of N. Accumbens dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.099
Differential adaptive properties of accumbens shell dopamine responses to ethanol as a drug and as a motivational stimulus 1.097
Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex 1.062
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.055
BEHAVIORAL AND BIOCHEMICAL CHARACTERIZATION OF THE ST1936, A NEW 5-HT6 AGONIST 1.048
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.048
Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances 1.048
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.037
Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats 1.036
Differential effects of natural and pharmacological rewards on dopamine transmission in the nucleus accumbens shell and core and in the prefrontal cortex 998
Responsiveness of mesolimbic and mesocortical dopamine transmission to bitter/aversive and sweet/palatable gustatory stimuli in fed ad libitum rats. 979
Differential responsiveness of shell/core/prefrontal dopamine transmission to taste stimuli 947
Dopamine Transmission and aversive motivation 902
Differential effect of morphine-conditioned and food-conditioned stimuli on dopamine release in the nucleus accumbens shell and core and in the prefrontal cortex 897
New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT 2 receptors in pharmacological and behavioral effects in the rat 804
Role of metabolism in rotenone neurotoxicity 765
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 752
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists 717
Characterization of the in vivo efficacy on dopaminergic and noradrenergic neurotransmission of a novel NK3 receptor antagonist: RO5313520. 710
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 698
Dopamine and drug addiction: the nucleus accumbens shell connection 696
METRONIDAZOLE TWO AMIDE PRODRUGS: SYNTHESIS, PSYCHOCHEMICAL PROPERTIES, STABILITY AND EX VIVO RELEASE STUDIES 652
Totale 182.938
Categoria #
all - tutte 232.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 232.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.547 0 0 0 0 0 0 0 0 0 0 0 1.547
2021/20229.336 1.220 574 509 896 753 489 452 601 954 1.136 937 815
2022/202314.739 1.263 1.932 1.861 1.010 876 1.788 836 1.078 1.001 990 1.417 687
2023/202415.805 683 655 561 860 1.404 2.170 2.365 2.183 765 1.009 1.597 1.553
2024/202521.925 3.522 4.047 4.220 2.877 2.073 1.476 2.037 206 381 312 362 412
2025/20269.375 623 501 946 793 727 609 1.604 518 598 1.721 445 290
Totale 188.297